<i>Retracted:</i> CDK4/6 inhibition suppresses tumour growth and enhances the effect of temozolomide in glioma cells

Yingxiao Cao, Xin Li, Shiqi Kong, Shuling Shang, Yanhui Qi

Open source

DOI
10.1111/jcmm.15156
Published
2020-04-11
Container
Journal of Cellular and Molecular Medicine
Publisher
Wiley
Open access
unknown

Credibility signals

serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/jcmm.15156,
  title = {<i>Retracted:</i>
                    CDK4/6 inhibition suppresses tumour growth and enhances the effect of temozolomide in glioma cells},
  author = {Yingxiao Cao and Xin Li and Shiqi Kong and Shuling Shang and Yanhui Qi},
  year = {2020},
  journal = {Journal of Cellular and Molecular Medicine},
  doi = {10.1111/jcmm.15156},
  url = {https://doi.org/10.1111/jcmm.15156}
}

RIS

TY  - JOUR
TI  - <i>Retracted:</i>
                    CDK4/6 inhibition suppresses tumour growth and enhances the effect of temozolomide in glioma cells
AU  - Yingxiao Cao
AU  - Xin Li
AU  - Shiqi Kong
AU  - Shuling Shang
AU  - Yanhui Qi
PY  - 2020
JO  - Journal of Cellular and Molecular Medicine
DO  - 10.1111/jcmm.15156
UR  - https://doi.org/10.1111/jcmm.15156
ER  - 

APA

Cao, Y., Li, X., Kong, S., Shang, S., & Qi, Y. (2020). <i>Retracted:</i> CDK4/6 inhibition suppresses tumour growth and enhances the effect of temozolomide in glioma cells. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.15156

Source records